These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3486740)

  • 1. Comparison of clindamycin, metronidazole, and penicillin for the treatment of experimental infections in mice caused by beta-lactamase-producing Bacteroides intermedius.
    Cockerill FR; Rosenblatt JE; Lee DT; Gay JD
    Diagn Microbiol Infect Dis; 1986 May; 5(1):25-30. PubMed ID: 3486740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.
    Brook I; Coolbaugh JC; Walker RI; Weiss E
    Antimicrob Agents Chemother; 1984 Jan; 25(1):71-7. PubMed ID: 6142680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo protection of group A beta-haemolytic streptococci from penicillin by beta-lactamase-producing Bacteroides species.
    Brook I; Pazzaglia G; Coolbaugh JC; Walker RI
    J Antimicrob Chemother; 1983 Dec; 12(6):599-606. PubMed ID: 6363381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo protection of penicillin-susceptible Bacteroides melaninogenicus from penicillin by facultative bacteria which produce beta-lactamase.
    Brook I; Pazzaglia G; Coolbaugh JC; Walker RI
    Can J Microbiol; 1984 Jan; 30(1):98-104. PubMed ID: 6143608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
    Thadepalli H; Chuah SK; Gollapudi S
    Chemotherapy; 2004 Jun; 50(2):76-80. PubMed ID: 15211081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy and pharmacokinetic properties of rifampicin in a Bacteroides fragilis intra-abdominal abscess.
    Fu KP; Lasinski ER; Zoganas HC; Kimble EF; Konopka EA
    J Antimicrob Chemother; 1984 Dec; 14(6):633-40. PubMed ID: 6520063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of an experimental Bacteroides fragilis infection in mice.
    Walker CB; Nitzan D; Wilkins TD
    Antimicrob Agents Chemother; 1977 Mar; 11(3):435-40. PubMed ID: 855998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
    J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact on peritonsillar infections and microflora of phenoxymethylpenicillin alone versus phenoxymethylpenicillin in combination with metronidazole.
    Tunér K; Nord CE
    Infection; 1986; 14(3):129-33. PubMed ID: 3089941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous metronidazole therapy for Bacteroides fragilis meningitis.
    Bryan CS; Huffman LJ; Del Bene VE; Sanders CV; Scalcini MC
    South Med J; 1979 Apr; 72(4):494-7. PubMed ID: 373128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metronidazole and spiramycin in abscesses caused by Bacteroides spp. and Staphylococcus aureus in mice.
    Brook I
    J Antimicrob Chemother; 1987 Nov; 20(5):713-8. PubMed ID: 3429373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of Bacteroides species to modern antimicrobial preparations.
    Závadová M; Tynková S; Adensámová J; Brezinová L
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(1):51-9. PubMed ID: 6602163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I
    Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimentally induced subcutaneous infection by black pigmented Bacteroides species in rats.
    Pancholi V; Ayyagari AS; Agarwal KC
    J Infect; 1985 Sep; 11(2):131-7. PubMed ID: 2865315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial drugs used in the management of anaerobic infections in children.
    Brook I
    Drugs; 1983 Dec; 26(6):520-9. PubMed ID: 6360636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic and clavulanic acid treatment of subcutaneous abscesses caused by Bacteroides fragilis alone or in combination with aerobic bacteria.
    Brook I; Coolbaugh JC; Walker RI
    J Infect Dis; 1983 Jul; 148(1):156-9. PubMed ID: 6350486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on bacterial synergism in mice infected with Bacteroides intermedius and Fusobacterium necrophorum.
    Price SB; McCallum RE
    J Basic Microbiol; 1987; 27(7):377-86. PubMed ID: 3449614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metronidazole and spiramycin therapy of mixed Bacteroides spp. and Neisseria gonorrhoeae infection in mice.
    Brook I
    Chemotherapy; 1989; 35(2):105-12. PubMed ID: 2503299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of beta-lactamase-producing bacteria and beta-lactamase activity in abscesses.
    Brook I
    Am J Clin Pathol; 1986 Jul; 86(1):97-101. PubMed ID: 3487973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
    Dijkmans BA; Vaishnav J; Mattie H
    Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.